Engineering pH-responsive mesoporous silica nanocarriers through maleated chitosan gating for controlled doxorubicin release
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Intraperitoneal and Appendiceal Malignancies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Nair A, Chandrashekhar HR, Day CM et al (2024) Polymeric functionalization of mesoporous silica nanoparticles: biomedical insights. Int J Pharm 660:124314. https://doi.org/10.1016/J.IJPHARM.2024.12431410.1016/J.IJPHARM.2024.124314 ↗
2. Saputra OA, Wibowo FR, Lestari WW (2022) High storage capacity of curcumin loaded onto hollow mesoporous silica nanoparticles prepared via improved hard-templating method optimized by Taguchi DoE. Eng Sci Technol Int J 33:101070. https://doi.org/10.1016/J.JESTCH.2021.10.00210.1016/J.JESTCH.2021.10.002 ↗
3. Wang G, Qi Y, Xu J et al (2023) Neutrophil membrane-coated mesoporous silica nanoparticles loaded with hydrocortisone alleviate DSS-induced colitis in mice. ACS Appl Nano Mater 6:2403–2412. https://doi.org/10.1021/ACSANM.2C0461510.1021/ACSANM.2C04615 ↗
4. Peng S, Huang B, Lin Y et al (2022) Effect of surface functionalization and pore structure type on the release performance of mesoporous silica nanoparticles. Microporous Mesoporous Mater 336:111862. https://doi.org/10.1016/J.MICROMESO.2022.11186210.1016/J.MICROMESO.2022.111862 ↗
5. Saputra OA, Lestari WA, Safitriono WN et al (2021) β-amino alcohol-based organosilane tailored magnetite embedded mesoporous silica nanoparticles exhibit controlled-release of curcumin triggered by pH. Mater Lett 305:130804. https://doi.org/10.1016/j.matlet.2021.13080410.1016/j.matlet.2021.130804 ↗
6. Duan F, Wang J, Li Z et al (2021) pH-responsive metal-organic framework-coated mesoporous silica nanoparticles for immunotherapy. ACS Appl Nano Mater 4:13398–13404. https://doi.org/10.1021/acsanm.1c0290810.1021/acsanm.1c02908 ↗
7. Dong JH, Ma Y, Li R et al (2021) Smart MSN-drug-delivery system for tumor cell targeting and tumor microenvironment release. ACS Appl Mater Interfaces 13:42522–42532. https://doi.org/10.1021/acsami.1c1418910.1021/acsami.1c14189 ↗
8. Mohanan S, Guan X, Liang M et al (2023) Stimuli-responsive silica silanol conjugates: strategic nanoarchitectonics in targeted drug delivery. Small. https://doi.org/10.1002/SMLL.20230111310.1002/SMLL.202301113 ↗
9. Abdo GG, Zagho MM, Khalil A (2020) Recent advances in stimuli-responsive drug release and targeting concepts using mesoporous silica nanoparticles. Emergent Mater 3(3):407–425. https://doi.org/10.1007/S42247-020-00109-X10.1007/S42247-020-00109-X ↗
10. Castillo RR, Lozano D, González B et al (2019) Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update. Expert Opin Drug Deliv 16:415–439. https://doi.org/10.1080/17425247.2019.159837510.1080/17425247.2019.1598375 ↗
11. Salve R, Kumar P, Ngamcherdtrakul W et al (2021) Stimuli-responsive mesoporous silica nanoparticles: a custom-tailored next generation approach in cargo delivery. Mater Sci Eng, C 124:112084. https://doi.org/10.1016/J.MSEC.2021.11208410.1016/J.MSEC.2021.112084 ↗
12. Li R, Feng C, Yang R et al (2022) Drug molecules bridge with small gatekeeper to co-block mesoporous silica nanoparticles for drug delivery. Colloids Surf B Biointerfaces 213:112350. https://doi.org/10.1016/J.COLSURFB.2022.11235010.1016/J.COLSURFB.2022.112350 ↗
13. Saputra OA, Lestari WA, Kurniansyah V, et al (2022) Organically surface engineered mesoporous silica nanoparticles control the release of quercetin by pH stimuli. Scientific Reports 2022 12:1 12:1–15. https://doi.org/10.1038/s41598-022-25095-410.1038/s41598-022-25095-4 ↗
14. Ruan S, Zhou Y, Jiang X, Gao H (2021) Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release. Adv Sci 8:2004025. https://doi.org/10.1002/ADVS.20200402510.1002/ADVS.202004025 ↗
15. Vega-Vásquez P, Mosier NS, Irudayaraj J (2020) Nanoscale drug delivery systems: from medicine to agriculture. Front Bioeng Biotechnol 8:507143. https://doi.org/10.3389/FBIOE.2020.00079/BIBTEX10.3389/FBIOE.2020.00079/BIBTEX ↗
16. Dinc R (2023) Magnetic nanoparticles with aspects of their use in cancer therapy. Lett Drug Des Discov 21:847–857. https://doi.org/10.2174/157018082066623022810390310.2174/1570180820666230228103903 ↗
17. Patra JK, Das G, Fraceto LF, et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 2018 16:1–33. https://doi.org/10.1186/S12951-018-0392-810.1186/S12951-018-0392-8 ↗
18. Huang P, Lian D, Ma H et al (2021) New advances in gated materials of mesoporous silica for drug controlled release. Chin Chem Lett 32:3696–3704. https://doi.org/10.1016/J.CCLET.2021.06.03410.1016/J.CCLET.2021.06.034 ↗
19. Oh JY, Yang G, Choi E, Ryu JH (2022) Mesoporous silica nanoparticle-supported nanocarriers with enhanced drug loading, encapsulation stability, and targeting efficiency. Biomater Sci 10:1448–1455. https://doi.org/10.1039/D2BM00010E10.1039/D2BM00010E ↗
20. Shahbaz S, Esmaeili M, Fathian Nasab MH et al (2024) PEGylated mesoporous silica core–shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells. Int J Pharm 655:124024. https://doi.org/10.1016/J.IJPHARM.2024.12402410.1016/J.IJPHARM.2024.124024 ↗
21. Cong VT, Houng JL, Kavallaris M et al (2022) How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells? Chem Soc Rev 51:7531–7559. https://doi.org/10.1039/D1CS00707F10.1039/D1CS00707F ↗
22. Ma X, Zhang J, Javed M et al (2023) Chitosan based smart polymer composites: fabrication and pH-responsive behavior for bio-medical applications. Environ Res 221:115286. https://doi.org/10.1016/J.ENVRES.2023.11528610.1016/J.ENVRES.2023.115286 ↗
23. Liao T, Liu C, Ren J et al (2021) A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a “tumor-triggered targeting” property. Int J Biol Macromol 183:2017–2029. https://doi.org/10.1016/J.IJBIOMAC.2021.06.00410.1016/J.IJBIOMAC.2021.06.004 ↗
24. Mistral J, Ve Koon KT, Fernando Cotica L et al (2024) Chitosan-coated superparamagnetic Fe3O4 nanoparticles for magnetic resonance imaging, magnetic hyperthermia, and drug delivery. ACS Appl Nano Mater 7:7097–7110. https://doi.org/10.1021/acsanm.3c0611810.1021/acsanm.3c06118 ↗
25. Saputra OA, Safitriono WN, Maharani DEK et al (2023) pH-controlled release feature of chitosan assembled silica nanoparticles containing nano-formulated curcumin over in vitro gastric and physiological condition. Food Biosci 53:10279310.1016/j.fbio.2023.102793 ↗
26. Nasab NA, Kumleh HH, Beygzadeh M et al (2018) Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif Cells Nanomed Biotechnol. 46:75–81. https://doi.org/10.1080/21691401.2017.129064810.1080/21691401.2017.1290648 ↗
27. Lohiya G, Katti DS (2022) Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy. Carbohydr Polym 277:118822. https://doi.org/10.1016/J.CARBPOL.2021.11882210.1016/J.CARBPOL.2021.118822 ↗
28. Kang S, Kim Y, Song Y et al (2014) Comparison of pH-sensitive degradability of maleic acid amide derivatives. Bioorg Med Chem Lett 24:2364–2367. https://doi.org/10.1016/J.BMCL.2014.03.05710.1016/J.BMCL.2014.03.057 ↗
29. Heck AG, Nuhn L (2024) Restoring the pH-responsiveness for amine-conjugated 2-propionic-3-methylmaleic anhydride linkers. Org Chem Front 11:4380–4384. https://doi.org/10.1039/D4QO01077A10.1039/D4QO01077A ↗
30. Gillies ER (2024) pH-sensitive polymer-drug conjugates. Chem Mater. https://doi.org/10.1021/acs.chemmater.4c0170010.1021/acs.chemmater.4c01700 ↗
31. Singh D, Vignat J, Lorenzoni V et al (2023) Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health 11:e197–e206. https://doi.org/10.1016/S2214-109X(22)00501-010.1016/S2214-109X(22)00501-0 ↗
32. Stelzle D, Tanaka LF, Lee KK et al (2021) Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health 9:e161–e169. https://doi.org/10.1016/S2214-109X(20)30459-910.1016/S2214-109X(20)30459-9 ↗
33. Ghosh S, Jayaram P, Kabekkodu SP, Satyamoorthy K (2022) Targeted drug delivery in cervical cancer: current perspectives. Eur J Pharmacol 917:174751. https://doi.org/10.1016/J.EJPHAR.2022.17475110.1016/J.EJPHAR.2022.174751 ↗
34. Wang X, Wang H, Mou X et al (2022) Lysophosphatidic acid protects cervical cancer HeLa cells from apoptosis induced by doxorubicin hydrochloride. Oncol Lett 24:267. https://doi.org/10.3892/ol.2022.1338710.3892/ol.2022.13387 ↗
35. Dey B, Kundu S, Sundara BK (2024) Polymeric nanostructures revolutionizing cervical cancer: diagnostics, therapeutics, and theranostics. BioNanoScience 2024:1–28. https://doi.org/10.1007/S12668-024-01496-910.1007/S12668-024-01496-9 ↗
36. Yang W, Song FX, Wang S et al (2021) Multifunctional mesoporous silica nanoparticles with different morphological characteristics for in vitro cancer treatment. Colloids Surf A 610:125717. https://doi.org/10.1016/J.COLSURFA.2020.12571710.1016/J.COLSURFA.2020.125717 ↗
37. Ghobadi M, Salehi S, Ardestani MTS et al (2024) Amine-functionalized mesoporous silica nanoparticles decorated by silver nanoparticles for delivery of doxorubicin in breast and cervical cancer cells. Eur J Pharm Biopharm 201:114349. https://doi.org/10.1016/J.EJPB.2024.11434910.1016/J.EJPB.2024.114349 ↗
38. Bano N, Ansari MI, Kainat KM et al (2023) Chloroquine synergizes doxorubicin efficacy in cervical cancer cells through flux impairment and down regulation of proteins involved in the fusion of autophagosomes to lysosomes. Biochem Biophys Res Commun 656:131–138. https://doi.org/10.1016/J.BBRC.2023.03.04810.1016/J.BBRC.2023.03.048 ↗
39. Linders AN, Dias IB, López Fernández T, et al (2024) A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. npj Aging 10:1–9. https://doi.org/10.1038/s41514-024-00135-710.1038/s41514-024-00135-7 ↗
40. Kciuk M, Gielecińska A, Mujwar S et al (2023) Doxorubicin—an agent with multiple mechanisms of anticancer activity. Cells 12:659. https://doi.org/10.3390/CELLS1204065910.3390/CELLS12040659 ↗
41. Ravishankar K, Shelly KM, Desingh RP et al (2018) Green, solid-state synthesis of maleated chitosan and ionotropic gelation with chitosan. ACS Sustain Chem Eng 6:15191–15200. https://doi.org/10.1021/acssuschemeng.8b0364810.1021/acssuschemeng.8b03648 ↗
42. Zhang Y, Huo M, Zhou J et al (2010) DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12:263–271. https://doi.org/10.1208/s12248-010-9185-110.1208/s12248-010-9185-1 ↗
43. Kumawat A, Karmakar M, Ghoroi C (2024) pH-responsive, reactive oxygen species scavenging and highly swellable nanogel for colon-targeted oral drug delivery. ACS Appl Nano Mater 7:18964–18978. https://doi.org/10.1021/acsanm.4c0276910.1021/acsanm.4c02769 ↗
44. Karimifard S, Rezaei N, Jamshidifar E et al (2022) PH-responsive chitosan-adorned niosome nanocarriers for co-delivery of drugs for breast cancer therapy. ACS Appl Nano Mater 5:8811–8825. https://doi.org/10.1021/acsanm.2c0086110.1021/acsanm.2c00861 ↗
45. Elkomy MH, Ali AA, Eid HM (2022) Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review. J Control Release 351:923–940. https://doi.org/10.1016/J.JCONREL.2022.10.00510.1016/J.JCONREL.2022.10.005 ↗
46. Huang Y, Li P, Zhao R et al (2022) Silica nanoparticles: biomedical applications and toxicity. Biomed Pharmacother 151:113053. https://doi.org/10.1016/j.biopha.2022.11305310.1016/j.biopha.2022.113053 ↗
47. Li CS, Liu J, Zhang Q et al (2025) Combined effect of nanoparticles of silver and silica to HeLa cells: synergistic internalization and toxicity. Environ Toxicol 40:802–816. https://doi.org/10.1002/tox.2448010.1002/tox.24480 ↗
48. Tonbul H, Sahin A, Tavukcuoglu E et al (2021) Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells. J Drug Deliv Sci Technol 63:102535. https://doi.org/10.1016/J.JDDST.2021.10253510.1016/J.JDDST.2021.102535 ↗
49. Zhang Q, Xiao Q, Yin H et al (2020) Milk-exosome based pH/light sensitive drug system to enhance anticancer activity against oral squamous cell carcinoma. RSC Adv 10:28314–28323. https://doi.org/10.1039/D0RA05630H10.1039/D0RA05630H ↗
50. Lee CS, Kim TW, Oh DE et al (2020) In vivo and in vitro anticancer activity of doxorubicin-loaded DNA-AuNP nanocarrier for the ovarian cancer treatment. Cancers 12:634. https://doi.org/10.3390/CANCERS1203063410.3390/CANCERS12030634 ↗